Academisch Medisch Centrum - Universiteit Van Amsterdam (amc-uva)
Clinical trials sponsored by Academisch Medisch Centrum - Universiteit Van Amsterdam (amc-uva), explained in plain language.
-
Zapping the heart: radiation may tame lethal rhythms
Disease control Recruiting nowThis study tests a precise, one-time radiation treatment for people with a dangerous heart rhythm called ventricular tachycardia that hasn't improved with medication or standard procedures. The goal is to see if this approach can cut the number of severe episodes by at least half…
Phase: PHASE2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
New personalized plan aims to prevent cancer in FAP patients after surgery
Disease control Recruiting nowThis study is for people with familial adenomatous polyposis (FAP) who have had their colon removed. It tests a personalized plan to regularly check and treat any new polyps in the remaining bowel. The goal is to keep the risk of advanced polyps or cancer very low (under 5% over …
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
Tailored surveillance could curb cancer risk in FAP patients
Disease control Recruiting nowThis study aims to see if a personalized schedule for checking and treating polyps in the stomach and duodenum can prevent cancer in people with familial adenomatous polyposis (FAP). About 1,000 adults with FAP will receive endoscopies and polyp removal based on their individual …
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
Could a blood filter cure long COVID? new trial aims to find out
Disease control Recruiting nowSome people with long COVID have symptoms like extreme fatigue because their immune system attacks their own body. This study tests a treatment called immunoadsorption, which filters the blood to remove harmful antibodies. About 70 adults with long COVID and these antibodies will…
Phase: PHASE2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
New hope for severe asthma sufferers: lung-heating procedure may slash attacks
Disease control Recruiting nowThis study tests a procedure called bronchial thermoplasty (BT) for people with severe asthma that remains uncontrolled even with biologic drugs. BT uses a thin tube to deliver heat to the airway walls, aiming to reduce asthma attacks and improve quality of life. About 90 adults …
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
Gut bacteria supplement may tame type 1 diabetes inflammation
Disease control Recruiting nowThis study tests whether taking a probiotic called Desulfovibrio piger for 4 weeks can lower inflammation and help preserve the body's own insulin production in people who have had type 1 diabetes for more than 5 years. Twenty adults with remaining beta cell function will receive…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Ultrasound-Guided fluid removal could shorten time on ventilators
Disease control Recruiting nowThis study tests whether using lung ultrasound to guide removal of extra fluid helps patients on breathing machines in the ICU breathe on their own sooner. About 1,000 adults who need a ventilator for at least another day will be randomly assigned to have fluid removal guided by …
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Could less blood pressure medicine save more lives in heart shock?
Disease control Recruiting nowThis study tests whether using less of the drug noradrenaline, by aiming for a lower blood pressure target (55 mmHg instead of 65 mmHg), can improve survival and reduce severe kidney failure in people with cardiogenic shock after a heart attack. About 776 adults will be randomly …
Phase: PHASE4 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 15, 2026 19:01 UTC
-
Shorter radiation course for esophageal cancer shows promise in new trial
Disease control Recruiting nowThis study tests a shorter, more intense radiation schedule combined with chemotherapy for people with locally advanced esophageal cancer. The goal is to see if this approach is safe and feasible, and to reduce side effects like low white blood cell counts. About 60 adults will r…
Phase: PHASE2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
Could a gut procedure help control diabetes? new trial begins
Disease control Recruiting nowThis study tests a procedure called duodenal mucosal resurfacing (DMR) for people with type 2 diabetes who take non-insulin medications. The treatment uses a thin tube to treat the lining of the upper gut, aiming to improve blood sugar control. The trial compares DMR to a sham (f…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
Balloon treatment may defuse hidden heart plaque bombs
Disease control Recruiting nowThis study tests whether a drug-coated balloon can reduce the fat content of dangerous plaques in heart arteries better than standard medications alone. It includes 400 adults who recently had a heart problem called acute coronary syndrome. Participants will be randomly assigned …
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New drug aims to quiet artery inflammation in heart disease patients
Disease control Recruiting nowThis study tests whether ziltivekimab, an anti-inflammatory drug, can reduce swelling in the heart's arteries. About 40 adults with heart disease and high inflammation will receive either the drug or a placebo. Researchers will use special scans and blood tests to see if the drug…
Phase: PHASE3 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC
-
Heart plaque reversal hope for young patients
Disease control Recruiting nowThis study tests whether early, aggressive cholesterol-lowering therapy can shrink artery plaques in 60 young adults (under 50) with familial high cholesterol. Participants will receive intensive treatment and have their plaque levels measured with CT scans. The goal is to see if…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
New trial aims to pinpoint optimal timing for local treatment in advanced stomach and esophageal cancers
Disease control Recruiting nowThis study looks at people with esophageal or stomach cancer that has spread to only a few spots (oligometastases). All participants receive 4 months of standard drug therapy, then are randomly assigned to either get local treatment (surgery or radiation) right away or after anot…
Phase: PHASE2, PHASE3 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
Ultrasound-Guided ventilation could save lives in ARDS
Disease control Recruiting nowThis study tests whether using lung ultrasound to personalize ventilator settings can reduce deaths in patients with acute respiratory distress syndrome (ARDS), a severe lung condition with about 30% mortality. About 538 adults on breathing machines will be randomly assigned to s…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC
-
Eczema patients may get longer breaks between injections
Disease control Recruiting nowThis study tests if people with well-controlled eczema can safely take their dupilumab injections less often. 216 adults will be randomly assigned to receive the drug every 2, 3, or 4 weeks. Researchers will compare eczema severity and quality of life to see if longer intervals w…
Phase: PHASE4 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 10, 2026 13:25 UTC
-
New combo therapy aims to slash deadly leaks after pancreatic cancer surgery
Disease control Recruiting nowThis trial tests whether giving three treatments together—two medicines and a surgical patch—can lower the risk of major complications after Whipple surgery for pancreatic cancer and other tumors. The study includes 400 high-risk patients with a small pancreatic duct. If successf…
Phase: PHASE4 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 10, 2026 13:24 UTC
-
Blood test could slash antibiotic use in preterm infants by 30%
Disease control Recruiting nowThis study tests whether adding a blood test called presepsin to standard care can safely reduce the number of preterm babies (born before 32 weeks) who receive antibiotics unnecessarily. Currently, over 85% of these infants get antibiotics right after birth due to infection risk…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 10, 2026 13:24 UTC
-
Heat therapy before stent may extend relief for bile duct cancer patients
Disease control Recruiting nowThis study tests whether using heat (radiofrequency ablation) before placing a metal stent helps keep the bile duct open longer in people with inoperable bile duct cancer. About 122 adults with this cancer will be randomly assigned to get the heat treatment plus a stent or just a…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 01, 2026 18:06 UTC
-
Ambulance EEG device could cut critical stroke treatment delays
Diagnosis Recruiting nowThis study tests a portable EEG device called StrokePointer that ambulance crews can use to quickly identify stroke patients who need to go directly to a hospital equipped for specialized clot-removal treatment. The goal is to reduce the average one-hour delay caused when patient…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Diagnosis
Last updated Jun 15, 2026 18:55 UTC
-
Could an antidepressant ease long COVID fatigue?
Symptom relief Recruiting nowThis study tests whether fluvoxamine, an antidepressant, can reduce severe fatigue and other symptoms in people with post-COVID. 160 adults aged 18-70 with long-lasting fatigue after COVID will receive either the drug or a placebo for 12 weeks. The goal is to see if it improves e…
Phase: PHASE3 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Symptom relief
Last updated Jun 15, 2026 19:05 UTC
-
Smarter brain stimulation could give Parkinson's patients more good hours each day
Symptom relief Recruiting nowThis study compares a newer, adaptive form of deep brain stimulation (aDBS) to the standard continuous stimulation (cDBS) in 130 people with Parkinson's disease. The goal is to see if aDBS increases the amount of time during the day when symptoms are well-controlled without causi…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Symptom relief
Last updated Jun 15, 2026 19:03 UTC
-
Diet and exercise may boost quality of life for incurable cancer patients
Symptom relief Recruiting nowThis study looks at whether a program of exercise and dietary changes can improve or maintain quality of life for people with incurable stomach or esophageal cancer. About 196 participants will either receive standard care or standard care plus the exercise and nutrition program.…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Symptom relief
Last updated Jun 15, 2026 18:55 UTC
-
Robot or laparoscope? new study seeks best way to remove pancreatic lesions
Symptom relief Recruiting nowThis study compares two minimally invasive surgeries—laparoscopic and robot-assisted—for removing the left side of the pancreas in people with benign (non-cancerous) or pre-cancerous growths. About 256 adults will be randomly assigned to one of the two procedures. The goal is to …
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Symptom relief
Last updated Jun 11, 2026 12:09 UTC
-
VR glasses could get stressed cabin crew back to work faster
Symptom relief Recruiting nowThis study tests whether using virtual reality (VR) to simulate the workplace helps cabin crew on sick leave for mental health issues return to work sooner. 118 participants will either get standard care or standard care plus at least one VR session. The goal is to see if VR redu…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Symptom relief
Last updated Jun 01, 2026 17:57 UTC
-
Less is more: thousands skip unnecessary cancer scans in landmark study
Knowledge-focused Recruiting nowThis study follows over 3,000 people with low-risk Barrett's esophagus who have stopped having routine endoscopic surveillance, as recommended by new guidelines. Researchers will track them for at least 10 years to see if stopping these scopes leads to a rise in serious esophagea…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:49 UTC
-
Spleen-Sparing surgery for pancreatic cancer: a safer future?
Knowledge-focused Recruiting nowThis study looks at whether removing the spleen during surgery for left-sided pancreatic cancer is always necessary. Currently, the spleen is taken out to remove any hidden cancer cells in the surrounding fat, but this can cause extra risks. By checking how often cancer actually …
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:09 UTC
-
Scientists probe immune cells to stop Crohn's Flare-Ups after surgery
Knowledge-focused Recruiting nowThis study aims to understand why Crohn's disease often comes back after surgery by looking at specific immune cells that respond to a protein called IL-23. Researchers will collect tissue samples from 40 adults with Crohn's who have had surgery and are receiving standard biologi…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:07 UTC
-
Diabetes heart risk under the microscope: 1,000 patients tracked
Knowledge-focused Recruiting nowThis study follows 1,000 people with type 2 diabetes who have already had a heart CT scan. Researchers will repeat the scan to measure how fatty plaque builds up in heart arteries over time. The goal is to better understand who is at highest risk for heart attacks and improve fut…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:08 UTC
-
Tilt table test may reduce fainting episodes, new study investigates
Knowledge-focused Recruiting nowThis study looks at whether using a tilt-table test, along with biofeedback training, can help people who faint due to vasovagal syncope. About 238 adults will be randomly assigned to either biofeedback with the tilt-table test or biofeedback alone. The goal is to see if the test…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:04 UTC
-
Women's heart surgery risks under the microscope
Knowledge-focused Recruiting nowThis study looks at how a condition called left ventricular diastolic dysfunction (stiff heart muscle) affects recovery in women after heart surgery. Researchers will track 1,000 patients to compare outcomes between men and women. The goal is to find ways to improve results for w…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:11 UTC
-
ICU fluid overload: scientists seek safer removal strategies
Knowledge-focused Recruiting nowThis study observes 150 ICU patients who need excess fluid removed. Researchers will track how fast and when fluid is removed, and look for signs of success or side effects like low blood pressure. The goal is to find safer, more personalized fluid removal methods, but this study…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:10 UTC
-
Heart artery balloon registry aims to refine blockage treatment
Knowledge-focused Recruiting nowThis study is collecting information from 3,000 people who receive a special drug-coated balloon to open blocked heart arteries. The goal is to see how effective and safe the balloon is in real-world use, including for different types of blockages and patient conditions. Research…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:28 UTC
-
Sugar test during surgery reveals liver secrets in obesity
Knowledge-focused Recruiting nowThis study looks at how the liver responds to a sugar injection during weight-loss surgery in 40 obese adults, some with fatty liver disease (MASLD) and some without. Researchers take small liver and fat samples before and after giving sugar or salt water to see which genes turn …
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:10 UTC
-
Could better blood tests help thyroid patients?
Knowledge-focused Recruiting nowThis study looks at whether additional lab tests, like fT3 and the fT3/fT4 ratio, can better measure thyroid hormone status in people with hypothyroidism who take levothyroxine. Researchers will compare these tests in 500 patients and healthy controls. The goal is to improve diag…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:17 UTC
-
Fainting study: is overnight stay worth it?
Knowledge-focused Recruiting nowThis study looks at people who faint (syncope) and are at low or medium risk for serious heart problems. It compares two common approaches: sending them home right away or keeping them in the hospital for 24 hours with heart monitoring. The goal is to find out which approach is s…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:12 UTC